top of page

Ongoing Clinical Trials in

Atypical Hemolytic Uremic Syndrome

IPTACOPAN


Uncontrolled activation of usually tightly regulated alternative complement pathway is the underlying pathogenesis in most cases of aHUS.

List of Updated Clinical Trials for C3G Glomerulopathy

bottom of page